Spruce Biosciences, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Equivalents | $48.9M | $38.8M | $96.3M | $24.5M | $42.7M | $157.2M | $3.9M |
| Accounts Receivable | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — |
| Total Current Assets | $52.1M | $44.2M | $102.2M | $83.6M | $91.9M | $160.4M | $4.7M |
| Property, Plant & Equipment | — | — | — | — | $140.0K | $73.0K | — |
| Goodwill | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — |
| Total Assets | $53.0M | $45.2M | $103.9M | $85.6M | $126.5M | $162.9M | $4.7M |
| Liabilities | |||||||
| Accounts Payable | $943.0K | $1.3M | $3.3M | $1.4M | $2.8M | $3.6M | $1.9M |
| Total Current Liabilities | $10.1M | $15.2M | $24.5M | $12.4M | $8.9M | $9.8M | $4.3M |
| Long-Term Debt | $0 | $124.0K | $1.7M | $3.3M | $4.9M | $1.9M | $3.2M |
| Total Liabilities | $10.5M | $16.4M | $27.4M | $17.2M | $15.1M | $13.5M | $7.5M |
| Stockholders' Equity | |||||||
| Retained Earnings | $-289.2M | $-250.3M | $-197.2M | $-149.3M | $-103.1M | $-60.8M | $-31.3M |
| Total Stockholders' Equity | $42.5M | $28.8M | $76.5M | $68.5M | $111.4M | $149.4M | $-30.6M |